First human test of Pfizer's new cancer drug begins
NCT ID NCT06799533
Summary
This early-stage study tested the safety and determined the right dosage of a new drug called PF-08046031 for adults with advanced melanoma and other solid tumors that have spread and have no other approved treatment options. The main goal was to identify side effects and see how the body processes the drug. The study was terminated early and did not progress to later phases to fully test how well the drug works against cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary â we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gustave Roussy
Villejuif, Val-de-marne, 94800, France
-
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [barcelona], 08035, Spain
-
Karolinska Universitetssjukhuset Solna
Solna, Stockholms LĂN [se-01], 171 64, Sweden
-
Presbyterian/ St. Lukes Medical Center
Denver, Colorado, 80218, United States
-
Sarah Cannon Research Institute at HealthONE - SCRI - PPDS
Denver, Colorado, 80218, United States
-
The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate
Los Angeles, California, 90025, United States
-
The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate
Los Angeles, California, 90025, United States
-
The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate (Emergency Back-up only)
Santa Monica, California, 90404, United States
-
The Royal Marsden NHS Foundation Trust
Sutton, SM2 5PT, United Kingdom
-
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94143, United States
-
UCSF Medical Center, Investigational Pharmacy
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.